{"issuance_frequency":"","notes_translated":{"fr":"Le présent guide est destiné aux entreprises de l'industrie du médicament et aux professionnels de la santé, dans le but de les aider à comprendre les mesures à prendre pour se conformer à la réglementation, plus précisément les exigences relatives aux licences d'établissements de produits pharmaceutiques (LEPP) inscrites à la partie C, titre 1A du RAD.","en":"These guidelines are meant to help companies in the drug manufacturing industry and health care professionals understand how to comply with regulations, specifically drug establishment licence (DEL) requirements in Part C, Division 1A of the FDR."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"2fbc20f0-f0c9-4493-9cec-4973568e9f96","metadata_created":"2020-09-17T17:41:13.302537","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-17T17:41:13.302543","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-09-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["licences d'établissement de produits pharmaceutiques","conformité à la réglementation sur les licences d'établissement de produits pharmaceutiques"],"en":["Drug Establishment Licences","comply with drug establishment licence regulation."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Document d'orientation sur les licences d'établissement de produits pharmaceutiques (GUI-0002) ","en":"Guidance on Drug Establishment Licences (GUI-0002)"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"2fbc20f0-f0c9-4493-9cec-4973568e9f96","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"11aea492-39eb-4e35-9fe7-fbca96808808","related_relationship":"","name_translated":{"fr":"Document d'orientation sur les licences d'établissement de produits pharmaceutiques (GUI-0002) ","en":"Guidance on Drug Establishment Licences (GUI-0002)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance on Drug Establishment Licences (GUI-0002)","language":["en"],"created":"2020-09-17T17:41:13.437632","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/guidance-drug-establishment-licences-drug-establishment-licensing-fees-0002.html","last_modified":null,"position":0,"revision_id":"77189f45-de3d-4fa9-bcac-15bc15dde0bb","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2fbc20f0-f0c9-4493-9cec-4973568e9f96","datastore_active":false,"id":"36f5866f-0bb8-405d-b8e5-9eb9762e1bc9","character_set":"","state":"active","name_translated":{"fr":"Document d'orientation sur les licences d'établissement de produits pharmaceutiques (GUI-0002) ","en":"Guidance on Drug Establishment Licences (GUI-0002)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance on Drug Establishment Licences (GUI-0002)","language":["fr"],"created":"2020-09-17T17:41:13.437637","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/licences-etablissement/directives-documents-orientation-politiques/document-orientation-licences-etablissement-prix-payer-licences-etablissement-0002.html","last_modified":null,"position":1,"revision_id":"77189f45-de3d-4fa9-bcac-15bc15dde0bb","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-04-01 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"2fbc20f0-f0c9-4493-9cec-4973568e9f96","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"These guidelines are meant to help companies in the drug manufacturing industry and health care professionals understand how to comply with regulations, specifically drug establishment licence (DEL) requirements in Part C, Division 1A of the FDR.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance on Drug Establishment Licences (GUI-0002)","revision_id":"77189f45-de3d-4fa9-bcac-15bc15dde0bb"}